½ðÄê»á¡¤(jinnianhui)½ð×ÖÕÐÅÆ³ÏÐÅÖÁÉÏ-Gold Annual Meeting

»¶Ó­À´µ½ÉϺ£Í¨Îµ£¡

021-54845833/15800441009

Æ·Öʱ£Ö¤ ¡¤ ͨεÊÔ¼Á

µ±Ç°Î»ÖÃ: Ê×Ò³ > ¿ÆÑвúÆ· > ¿ÆÑп¹Ìå > Ò»¿¹ > Íÿ¹RELB (Phospho-Ser573) ¶à¿Ë¡¿¹Ìå

²úÆ·ÖÐÐÄ

×îвúÆ·

  • Íÿ¹RELB (Phospho-Ser573) ¶à¿Ë¡¿¹Ìå

    ¹æ¸ñ£º
    ¼Û¸ñ£º£¤
    • Æ·ÅÆ : ͨεÉúÎï
    • Ŀ¼ºÅ : TW20032
    • Ó¦Óà : ½ö¹©¿ÆÑÐʹÓÃ
    • »õÆÚ : ÏÖ»õ
    • ¹æ¸ñ £º100ul/200ul/25ul
  • ÉÌÆ·ÏêÇé
  • ²Î¿¼ÎÄÏ×
  • ˵Ã÷ÊéÏÂÔØ
  • ÉÌÆ·ÆÀÂÛ0
  • Ïà¹Ø²úÆ·

ÖÐÎÄÃû³Æ£º  Íÿ¹RELB (Phospho-Ser573) ¶à¿Ë¡¿¹Ìå   

Ó¢ÎÄÃû³Æ£º Anti-RELB (Phospho-Ser573) rabbit polyclonal antibody

±ð    Ãû£º IREL; I-REL; REL-B

Ïà¹ØÀà±ð£º Ò»¿¹

´¢    ´æ£º Àä¶³£¨-20¡æ£© ±Ü¹â

ËÞ    Ö÷£º Rabbit

¿¹    Ô­£º RELB (Phospho-Ser573)

·´Ó¦ÖÖÊô£º Human Mouse Rat

±ê ¼Ç Î Unconjugate

¿Ë¡ÀàÐÍ£º rabbit polyclonal


¼¼Êõ¹æ¸ñ

Background:

NF-kappa-B is a pleiotropic transcription factor which is present in almost all cell types and is involved in many biological processed such as inflammation, immunity, differentiation, cell growth, tumorigenesis and apoptosis. NF-kappa-B is a homo- or heterodimeric complex formed by the Rel-like domain-containing proteins RELA/p65, RELB, NFKB1/p105, NFKB1/p50, REL and NFKB2/p52. The dimers bind at kappa-B sites in the DNA of their target genes and the individual dimers have distinct preferences for different kappa-B sites that they can bind with distinguishable affinity and specificity. Different dimer combinations act as transcriptional activators or repressors, respectively. NF-kappa-B is controlled by various mechanisms of post-translational modification and subcellular compartmentalization as well as by interactions with other cofactors or corepressors. NF-kappa-B complexes are held in the cytoplasm in an inactive state complexed with members of the NF-kappa-B inhibitor (I-kappa-B) family. In a conventional activation pathway, I-kappa-B is phosphorylated by I-kappa-B kinases (IKKs) in response to different activators, subsequently degraded thus liberating the active NF-kappa-B complex which translocates to the nucleus. NF-kappa-B heterodimeric RelB-p50 and RelB-p52 complexes are transcriptional activators.

Applications:

WB, IHC

Name of antibody:

RELB (Phospho-Ser573)

Immunogen:

Synthetic peptide of human RELB (Phospho-Ser573)

Full name:

v-rel reticuloendotheliosis viral oncogene homolog B (Phospho-Ser573)

Synonyms£º

IREL; I-REL; REL-B

SwissProt:

Q01201

IHC positive control:

Human breast carcinoma

IHC Recommend dilution:

50-100

WB Recommended dilution:

500-1000

WB Positive control:

HUVEC cells untreated or treated with TNF

WB Predicted band size:

70 kDa





¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿
¡¾ÍøÕ¾µØÍ¼¡¿¡¾sitemap¡¿